CONSOLIDATED BALANCE SHEETS (UNAUDITED) (USD $) In Millions, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Current Assets:
Cash and cash equivalents	$ 4,282	$ 3,586
Marketable Securities, Current	2,893	939
Receivables	3,315	3,360
Inventories	1,666	1,498
Deferred income taxes	1,356	1,701
Prepaid expenses and other	512	412
Assets held-for-sale, Current	38	7,420
Total Current Assets	14,062	18,916
Property, plant and equipment	4,438	4,579
Goodwill	7,046	7,096
Other intangible assets	1,843	2,318
Deferred income taxes	875	508
Marketable Securities, Noncurrent	3,876	3,747
Other assets	1,363	1,428
Total Assets	33,503	38,592
Current Liabilities:
Short-term borrowings and current portion of long-term debt	365	359
Accounts payable	2,405	2,559
Accrued expenses	2,204	2,152
Deferred income	1,090	756
Accrued rebates and returns	909	889
Income taxes payable	204	160
Dividends payable	621	634
Liabilities related to assets held-for-sale		4,931
Total Current Liabilities	7,798	12,440
Pension, postretirement, and postemployment liabilities	681	718
Deferred income	1,042	769
Income taxes payable	545	750
Deferred income taxes	62	73
Other liabilities	624	625
Long-term debt	7,372	7,981
Total Liabilities	18,124	23,356
Commitments and contingencies (Note 19)
Bristol-Myers Squibb Company Shareholders' Equity:
Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 4,252 in 2014 and 4,369 in 2013, liquidation value of $50 per share	0	0
Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.2 billion issued in both 2014 and 2013	221	221
Capital in excess of par value of stock	1,479	1,922
Accumulated other comprehensive loss	(2,225)	(2,141)
Retained earnings	33,026	32,952
Less cost of treasury stock - 551 million common shares in 2014 and 559 million in 2013	(17,174)	(17,800)
Total Bristol-Myers Squibb Company Shareholders' Equity	15,327	15,154
Noncontrolling interest	52	82
Total Equity	15,379	15,236
Total Liabilities and Equity	$ 33,503	$ 38,592